Akero Therapeutics Inc share price logo

Akero Therapeutics Inc Share Price

NASDAQ: AKRO

Small Cap

$42.72

-0.74

(-1.70%)

Live

as on

Akero Therapeutics Inc Stock Performance

as on September 15, 2025 at 11:36 pm IST

  • Day's Low

    Day's High

    $41.77
    $43.73
    downward going graph

    2.22%

    Downside

    2.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $21.34
    $58.4
    downward going graph

    50.05%

    Downside

    36.70%

    Upside

    downward going graph

Akero Therapeutics Inc share price movements today

Previous Close
$43.46
Open
$43.73
Volume
557.7K
Day's Low - High
$41.77 - $43.73
52 Week Low - High
$21.34 - $58.4

Akero Therapeutics Inc Historical Returns

1 Month Return
-11.99 %
3 Month Return
-21.86 %
1 Year Return
+ 58.96 %
3 Year Return
+ 63.81 %
5 Year Return
+ 20.19 %

Akero Therapeutics Inc Stock Fundamentals & Key Indicators

Check Akero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5B

EPS (TTM)

-3.7181

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-321.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

24090100.00%

Akero Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akero Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.5B20.19%NA0.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Akero Therapeutics Inc Stock including INR - Dollar returns

The Akero Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Akero Therapeutics Inc investment value today

Current value as on today

₹1,61,240

Returns

₹61,240

(+61.24%)

Returns from Akero Therapeutics Inc Stock

₹56,255 (+56.25%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Akero Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Akero Therapeutics Inc. Average target price of $77.3

Akero Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Akero Therapeutics Inc.

What analysts predicted

44.73%UPSIDE

Target Price

$77.3

Current Price

$42.72

Analyzed by

16 Analysts

Target

$77.30

Akero Therapeutics Inc target price $77.3, a slight upside of 44.73% compared to current price of $42.72. According to 16 analysts rating.

Akero Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Akero Therapeutics Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Akero Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
-
Operating Income
-28
-35
-46
-61
-59
-65
-81
-78
-80
-80
EBITDA
-25
-30
-38
-54
-52
-54
-71
-68
-69
-69
Interest Expense
0
0
0
0
0
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
-
-
Income Before Tax
-25
-31
-39
-55
-53
-55
-72
-70
-70
-70
Income Tax Expense
-2
6
8
-12
0
0
-
-
-
-
Net Income
-23
-31
-39
-55
-53
-55
-72
-70
-70
-70
Net Profit Margin
0.00%
0.00%
0.00%
-19431.69%
0.00%
0.00%
0.00%
-1750600.00%
0.00%
0.00%

Akero Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-80
-100
0
0
0
Operating Income
-4
-13
-45
-80
-100
-115
-172
-285
EBITDA
0
-68
-45
-80
-100
-111
-148
-285
Interest Expense
-
-
-
-
0
0
3
4
Depreciation
-
-
-
0
0
0
0
0
Income Before Tax
-4
-81
-43
-79
-100
-112
-151
-252
Income Tax Expense
-4
-68
-1
0
0
-3
-
-
Net Income
-4
-81
-43
-79
-100
-108
-151
-252
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Akero Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-31
-39
-55
-53
-55
-72
-70
-70
-70
Operating Cash Flow
-22
-49
-48
-35
-57
-70
-67
-67
-48
Investing Cash Flow
-128
-125
12
57
-255
73
15
-482
79
Financing Cash Flow
336
0
0
366
0
3
75
395
3
Change in Cash
186
-174
-35
389
-313
5
24
-154
34

Akero Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-81
-43
-79
-100
-112
-151
-252
Operating Cash Flow
-4
-35
-70
-79
-92
-145
-230
Investing Cash Flow
-5
-71
-9
42
-63
-223
-109
Financing Cash Flow
85
95
203
0
255
353
445
Change in Cash
75
-11
122
-36
99
-15
106

Global Institutional Holdings in Akero Therapeutics Inc

Funds
Holdings
RTW INVESTMENTS, LLC
9.28%
HHG PLC
8.84%
BlackRock Inc
7.82%
Wellington Management Company LLP
7.42%
General Atlantic Llc
6.54%

Insights on Akero Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 16.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 59.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AKRO stock has moved down by -12.0%

About Akero Therapeutics Inc

akero therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (nash) and other serious metabolic diseases. akero's lead clinical program, akr-001, is a long-acting fc fusion modified fgf21 protein and potential best-in-class treatment for nash. akr-001 builds upon two decades of work on fgf21 biology. it is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.
OrganisationAkero Therapeutics Inc
Headquarters601 Gateway Boulevard, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEODr. Andrew Cheng M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Akero Therapeutics Inc

Name

Title

Dr. Andrew Cheng M.D., Ph.D.

President, CEO & Director

Dr. Jonathan M. Young J.D., Ph.D.

Co-Founder, Executive VP, COO & Secretary

Mr. Scott A. Gangloff

Chief Technical Officer

Mr. Thomas Ross

Senior VP & Head of Legal

Mr. William R. White J.D.

Executive VP, CFO, Treasurer & Head of Corporate Development

Ms. Catriona Yale

Executive VP & Chief Development Officer

Dr. Timothy Rolph Ph.D.

Co-Founder & Chief Scientific Officer

Mr. John J. Schembri

Senior VP & Head of Finance

Mr. Patrick Lamy

Senior Vice President of Commercial Strategy

FAQs

What is Akero Therapeutics Inc share price today?

Akero Therapeutics Inc share price today is $42.72 as on . Akero Therapeutics Inc share today touched a day high of $43.73 and a low of $41.77.

What is the 52 week high and 52 week low for Akero Therapeutics Inc share?

Akero Therapeutics Inc share touched a 52 week high of $58.4 on and a 52 week low of $21.34 on . Akero Therapeutics Inc stock price today i.e. is trending at $42.72,which is 26.85% down from its 52 week high and 100.19% up from its 52 week low.

What is Akero Therapeutics Inc's market capitalisation today?

Akero Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Akero Therapeutics Inc Stock (AKRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Akero Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akero Therapeutics Inc Shares that will get you 0.0351 shares as per Akero Therapeutics Inc share price of $42.72 per share as on September 15, 2025 at 11:36 pm IST.

What is the minimum amount required to buy Akero Therapeutics Inc Stock (AKRO) from India?

Indian investors can start investing in Akero Therapeutics Inc (AKRO) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Akero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Akero Therapeutics Inc share’s latest price of $42.72 as on September 15, 2025 at 11:36 pm IST, you will get 0.2341 shares of Akero Therapeutics Inc. Learn more about fractional shares .

What are the returns that Akero Therapeutics Inc has given to Indian investors in the last 5 years?

Akero Therapeutics Inc stock has given 20.19% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?